Skip to content
Home/Companies/Biotech/Biose
Biose

Biose

Biotech·France·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Biose?

Biose is currently owned by Siparex through Siparex Territoires (2021 vintage), since 2021.

Hand-verified · updated 2026-04-21

Siparex
Investor
Siparex
Siparex Territoires · 2021 · Growth

Key facts

HQFrance
SectorBiotech
Websitewww.biose.com

More from Siparex Territoires

Other portfolio companies in the same fund.

Dreyer
Dreyer
Active
IndustrialsFrance· 2025
Les CoPains
Les CoPains
Active
ConsumerFrance· 2025
Pralus
Pralus
Active
ConsumerFrance· 2025
SAF Aerogroup
Active
Business ServicesFrance· 2025
Chovet
Chovet
Active
Business ServicesFrance· 2023
Groupe Off
Active
ConsumerFrance· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Biose

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Biose?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Biose.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue